Fabio Del Bello

23PUBLICATIONS
50CO-AUTHORS
Molecular targetsMain group metal chemistryMetal organic frameworksBiologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 13, 2026
Probing chemical space and conformational changes for subtype-selective orexin receptor antagonists.

|May 25, 2026
Synthesis, Structural Insights, and In Vitro Evaluation of Novel Silver Complexes Supported by Amantadine-Functionalized Bis(pyrazolyl)acetate Ligands as Anticancer Agents.

|Feb 13, 2026
Synthesis, Structural Studies, and Biological Evaluation of Copper(I) and Copper(II) Complexes Supported by Bis(pyrazol-1-yl)acetate Ligand Functionalized with Amantadine for the Treatment of Glioblastoma.

Sofia Migani, Giuseppina Bozzuto, Annarica Calcabrini

|Mar 29, 2025
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma.

Federica Matteucci, Pegi Pavletić, Alessandro Bonifazi

|Jul 26, 2024
New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2.

Gianfabio Giorgioni, Alessandro Bonifazi, Rosanna Matucci

|Jun 27, 2024
Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes.

Federica Matteucci, Marta Ferrati, Eleonora Spinozzi

Pageof 4

Frequent Collaborators

14 joint publications

Gianfabio Giorgioni

13 joint publications

Wilma Quaglia

10 joint publications

Alessandro Piergentili

9 joint publications

Alessandro Bonifazi